267 results on '"Lönnroth K"'
Search Results
2. Different disease, same challenges: Social determinants of tuberculosis and COVID-19
3. Towards tuberculosis elimination: An action framework for low-incidence countries
4. Multidrug-resistant tuberculosis and migration to Europe
5. Reducing the burden of TB among migrants to low TB incidence countries
6. The household economic burden of drug-susceptible TB diagnosis and treatment in The Gambia
7. Country differences and determinants of yield in programmatic migrant TB screening in four European countries
8. The burden of disease due to COVID-19 in Sweden: a disability-adjusted life years (DALY) study
9. Drivers determining active TB screening yield in different European screening programmes: a comparative analysis.
10. Modelling the impact of social protection on tuberculosis: the S-PROTECT project
11. Evaluation of COVID-19 screening for international travellers
12. Additional file 1 of The socioeconomic impact of tuberculosis on children and adolescents: a scoping review and conceptual framework
13. Undernutrition can no longer be an afterthought for global efforts to eliminate TB
14. Health-related quality of life among persons treated for tuberculosis in a European setting
15. ScreenTB: a tool for prioritising risk groups and selecting algorithms for screening for active tuberculosis
16. Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks
17. Drug Utilisation: What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden
18. Defining a migrant-inclusive tuberculosis research agenda to end TB [+ Erratum IJTLD.2018, vol. 22, no 10, p. 1244]
19. Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks
20. Catastrophic health costs averted by TB control: findings for India and South Africa from a modeling study
21. Modelling the social and structural determinants of TB: opportunities and challenges
22. Measuring catastrophic costs due to tuberculosis in Viet Nam
23. Defining a migrant-inclusive tuberculosis research agenda to end TB
24. Tuberculosis, social determinants and co-morbidities (including HIV)
25. Valuable but incomplete! Migrants’ perspectives on health examination in Stockholm
26. Methodological considerations for economic modelling of latent tuberculous infection screening in migrants
27. Response to Letter to the Editor by M. van der Werf, V. Hollo and C. Ködmön concerning ‘Multidrug-resistant tuberculosis and migration to Europe’
28. Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points
29. The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review
30. Systematic screening for active tuberculosis: rationale, definitions and key considerations
31. Cash transfer and microfinance interventions for tuberculosis control: Review of the impact evidence and policy implications
32. Diabetes mellitus and tuberculosis: programmatic management issues
33. Tuberculosis, social determinants and co-morbidities (including HIV)
34. The looming epidemic of diabetes-associated tuberculosis:learning lessons from HIV-associated tuberculosis
35. Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review [Review article]
36. Programmatic approaches to screening for active tuberculosis [State of the art series. Active case finding/screening. Number 6 in the series]
37. Free tuberculosis diagnosis and treatment are not enough: patient cost evidence from three continents
38. The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis
39. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications
40. Measuring socio-economic data in tuberculosis prevalence surveys
41. Tuberculosis and poverty: what is being done [Counterpoint]
42. Trends in tuberculosis incidence and their determinants in 134 countries
43. PHP22 EFFECTS OF DECENTRALIZED RESPONSIBILITY FOR COSTS OF OUTPATIENT PRESCRIPTION DRUGS ON THE PHARMACEUTICAL COST DEVELOPMENT IN SWEDEN
44. PHP17 EFFECTS OF GENERIC SUBSTITUTION ON THE DEVELOPMENT OF PHARMACEUTICAL EXPENDITURES DURING THE PERIOD JANUARY I 998 TO MAY 2005
45. Bi-directional screening for tuberculosis and diabetes: a systematic review.
46. Effects of a co-financed interdisciplinary collaboration model in primary health care on service utilisation among patients with musculoskeletal disorders.
47. Hard gains through soft contracts: productive engagement of private providers in tuberculosis control.
48. Effects of co-financed interdisciplinary teamwork on sick leave for people with musculoskeletal disorders.
49. Utilization of private and public health-care providers for tuberculosis symptoms in Ho Chi Minh City, Vietnam.
50. Rautatietavaravaunun hitsatun aluskehyksen suunnittelu
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.